23 results on '"Sarosi, Veronika"'
Search Results
2. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
3. Cisplatin treatment induced interleukin 6 and 8 production alters lung adenocarcinoma cell migration in an oncogenic mutation dependent manner
4. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
5. Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE)
6. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
7. Alteration in the Wnt microenvironment directly regulates molecular events leading to pulmonary senescence
8. KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
9. PET-CT Imaging and Reality
10. Age and gender specific lung cancer incidence and mortality in Hungary: Trends from 2011 through 2016.
11. Improvement in lung cancer survival: Six-year survival analysis of patients diagnosed between 2011 and 2016 in Hungary.
12. Cigarette Smoke-Induced Pulmonary Inflammation Becomes Systemic by Circulating Extracellular Vesicles Containing Wnt5a and Inflammatory Cytokines
13. Lung Cancer in Hungary
14. Second-Line Afatinib for Advanced Squamous Cell Carcinoma of the Lung: Analysis of Afatinib Long-Term Responders in the Phase III LUX-Lung 8 Trial
15. OA23.03 Second-Line Afatinib for Advanced Squamous Cell Carcinoma of the Lung: Analysis of Afatinib Long-Term Responders in the Phase III LUX-Lung 8 Trial
16. L-arginine pathway metabolites can predict exacerbation independently from beta blocker treatment in patients with COPD: A follow-up study
17. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker
18. The efficacy of bevacizumab in addition to platinum-based chemotherapy for first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer (NSCLC): Final results of AVALANCHE, an observational cohort study.
19. Effectiveness of erlotinib in lung adenocarcinomas with classic and alternative EGFR mutations detected by Roche 454 GS-FLX next-generation sequencing (NGS).
20. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
21. PET-CT Imaging and Reality
22. Forme Fruste of Churg–Strauss syndrome diagnosed by transbronchial biopsy: A case report
23. 2 The Hungarian experience with gemcitabine-cisplatin as first-line treatment of advanced non-small cell lung cancer: Focus on safety profile
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.